ECSP993146A - TREATMENT METHOD FOR DIABETES USING AN AP2 INHIBITOR AND ITS COMBINATION - Google Patents
TREATMENT METHOD FOR DIABETES USING AN AP2 INHIBITOR AND ITS COMBINATIONInfo
- Publication number
- ECSP993146A ECSP993146A ECSP993146A ECSP993146A EC SP993146 A ECSP993146 A EC SP993146A EC SP993146 A ECSP993146 A EC SP993146A EC SP993146 A ECSP993146 A EC SP993146A
- Authority
- EC
- Ecuador
- Prior art keywords
- inhibitor
- diabetes
- combination
- treatment method
- glyburide
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 3
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 229940125708 antidiabetic agent Drugs 0.000 abstract 1
- 239000003472 antidiabetic agent Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229960004580 glibenclamide Drugs 0.000 abstract 1
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 abstract 1
- 229960003105 metformin Drugs 0.000 abstract 1
- GXPHKUHSUJUWKP-UHFFFAOYSA-N troglitazone Chemical compound C1CC=2C(C)=C(O)C(C)=C(C)C=2OC1(C)COC(C=C1)=CC=C1CC1SC(=O)NC1=O GXPHKUHSUJUWKP-UHFFFAOYSA-N 0.000 abstract 1
- 229960001641 troglitazone Drugs 0.000 abstract 1
- GXPHKUHSUJUWKP-NTKDMRAZSA-N troglitazone Natural products C([C@@]1(OC=2C(C)=C(C(=C(C)C=2CC1)O)C)C)OC(C=C1)=CC=C1C[C@H]1SC(=O)NC1=O GXPHKUHSUJUWKP-NTKDMRAZSA-N 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se provee un método para tratar la diabetes y enfermedades relacionadas, especialmente la diabetes tipo II, empleando un inhibidor AP2 o una combinación de un inhibidor AP2 y otros agentes antidiabéticos como el metformin, gliburida, troglitazone y/o insulina.A method of treating diabetes and related diseases, especially type II diabetes, is provided using an AP2 inhibitor or a combination of an AP2 inhibitor and other antidiabetic agents such as metformin, glyburide, troglitazone and / or insulin.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP993146 ECSP993146A (en) | 1999-09-17 | 1999-09-17 | TREATMENT METHOD FOR DIABETES USING AN AP2 INHIBITOR AND ITS COMBINATION |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP993146 ECSP993146A (en) | 1999-09-17 | 1999-09-17 | TREATMENT METHOD FOR DIABETES USING AN AP2 INHIBITOR AND ITS COMBINATION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP993146A true ECSP993146A (en) | 1999-11-29 |
Family
ID=42044134
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP993146 ECSP993146A (en) | 1999-09-17 | 1999-09-17 | TREATMENT METHOD FOR DIABETES USING AN AP2 INHIBITOR AND ITS COMBINATION |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP993146A (en) |
-
1999
- 1999-09-17 EC ECSP993146 patent/ECSP993146A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY25713A1 (en) | METHOD FOR TREATING DIABETES USING AN AP2 INHIBITOR AND COMBINATION. | |
| LT2001092A (en) | HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND USE THEREOF | |
| UY34691A (en) | FUSIONED PIRROLIDINE BASED INHIBITORS WITH DIPEPTIDIL PEPTIDASE IV CYCLOPROPYL AND METHOD | |
| BR0111800A (en) | Depeptidyl peptidase iv inhibitor combinations and other antidiabetic agents for the treatment of diabetes mellitus | |
| DE60333605D1 (en) | Tuberculosis treatment with pleuromutilin derivatives | |
| DK1333887T3 (en) | Combination therapy including antidiabetic and anticonvulsant agents | |
| AR017819A1 (en) | METFORMINE SALTS, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, THERAPEUTIC METHODS THAT APPLY SUCH COMPOUNDS AND THE COMBINATIONS OF THESE COMPOUNDS WITH OTHER THERAPEUTIC AGENTS | |
| BR0309278A (en) | Compound, composition, methods for modulating ksp kinesin activity, for inhibiting ksp, for the treatment of a cell proliferative disease, and use of a compound | |
| DE60238255D1 (en) | AZOLIC ACID DERIVATIVES, ALONE OR COMBINED, FOR THE TREATMENT OF DIABETES AND DYSLIPIDAEMIA; AND FOR THE TREATMENT OF MALIGNES DISEASES | |
| CY1106336T1 (en) | DERIVATIVES OF ETEOCYCLIC ACIDS, THEIR METHOD OF PREPARATION AND THEIR USE IN THE THERAPEUTIC TREATMENT OF TYPE II DIABETES | |
| PY0224080A (en) | ALKYNES AS MATRIX METALLOPROTEINASE INHIBITORS | |
| HN1999000184A (en) | COMBINATIONS FOR DIABETES | |
| DE60026146D1 (en) | USE OF DAPOXETINE, A SELECTIVE SEROTONEIN INHIBITOR WITH A QUICK INITIAL ACTIVITY, FOR THE TREATMENT OF SEXUAL DYSFUNCTION | |
| PT790824E (en) | CARBOXYLIC ACID 2,2-DICHLOROALCANES MEDICATIONS CONTAINING THE SAME AND ITS USE FOR THE TREATMENT OF INSULIN RESISTANCE | |
| BR0011339A (en) | Compound, use, and process for preparing the same, pharmaceutical composition, and method for treating a metalloproteinase-mediated disease condition | |
| ECSP993146A (en) | TREATMENT METHOD FOR DIABETES USING AN AP2 INHIBITOR AND ITS COMBINATION | |
| DK1237562T3 (en) | Process for the preparation of micania extracts containing micanolide and dihydromycanolide and use in the treatment of proliferative diseases | |
| PE89199A1 (en) | PHARMACEUTICAL COMPOSITION OF TIAZOLIDINADIONA AND AN ALPHA GLUCOSIDASE INHIBITOR FOR THE TREATMENT OF DIABETES | |
| AR043327A1 (en) | USE OF QUINURENINE 3- HYDROXYLASE INHIBITORS FOR THE TREATMENT OF DIABETES | |
| ATE252383T1 (en) | USE OF 2-METHYL-THIAZOLIDINE-2,4-DICARBONIC ACID AND/OR ITS PHYSIOLOGICALLY TOLERABLE SALTS FOR THE PRODUCTION OF A MEDICATION FOR THE TREATMENT OF CANCER DISEASES | |
| TR200000133T2 (en) | Treatment of diabetes (diabetic) with thiazolidinedione, insulin secretagogue and alpha glucosidase inhibitor. | |
| ATE346601T1 (en) | USE OF ANTIDIABETIC DRUGS FOR THE PRODUCTION OF A SCARING PROMOTING MEDICINAL PRODUCT | |
| BR0209400A (en) | Fabric Care Composition, Process for Tissue Treatment, and, Use of a Composition | |
| ES2174748B1 (en) | NEW SALT OF TIAZOLIDINDIONA AND ITS POLYMORPHES AS ANTI-DIABETIC AGENTS AND PROCEDURE FOR OBTAINING THEMSELVES. | |
| ECSP003408A (en) | Biphenyl aPz inhibitors containing heterocyclic compounds and method |